Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma

Radioimmunotherapy treatment using 177Lu-DOTA-Rituximab shown to be both safe and feasible for Lymphoma patients

Stanford University Study Shows Improvements in Overall Survival for Follicular Grade 1-2 Lymphoma Patients from 1960-2003

Ontario funds rituximab for the treatment of relapsed Chronic Lymphocytic Leukemia (CLL)

Canadian Provinces Fund New Treatment for patients with indolent non-Hodgkin’s Lymphoma (iNHL) and Mantle Cell Lymphoma (MCL)

Obinutuzumab (GA101) Significantly Improved Progression-Free Survival in People With Chronic Lymphocytic Leukemia (CLL)

Health Canada Approves ADCETRIS®

BC Cancer Agency Scientists Unlock Lymphoma Clues

Cancer Advocacy Coalition of Canada (CAC) releases the 2010-2011 Report Card on Cancer in Canada

Major Discovery by BC Cancer Agency